Current approaches to unravel the mystery of dilated cardiomyopathy, a common cause of hereditary heart failure

References

• Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93, 841–842 (1996).
   PubMed Web of Science ®Google Scholar
• Towbin JA, Bowles NE. The failing heart. Nature 415, 227–233 (2002).
   PubMed Web of Science ®Google Scholar
• Mestroni L, Maisch B, McKenna WJ et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur. Heart J. 20, 93–102 (1999).
   PubMed Web of Science ®Google Scholar
• Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation 80, 564–572 (1989).
   PubMed Web of Science ®Google Scholar
• Cohn JN, Bristow MR, Chien KR et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95, 766–770 (1997).
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327, 685–691 (1992).
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 327, 669–677 (1992).
   PubMed Web of Science ®Google Scholar
• Waagstein F, Bristow MR, Swedberg K et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342, 1441–1446 (1993).
   PubMed Web of Science ®Google Scholar
• Poole-Wilson PA, Swedberg K, Cleland JG et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362, 7–13 (2003).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Pennell DJ, Ray SG et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet 362, 14–21 (2003).
   PubMed Web of Science ®Google Scholar
• Molhoek SG, Bax JJ, van Erven L et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am. J. Cardiol. 93, 860–863 (2004).
   Google Scholar
• Mortensen PT, Sogaard P, Mansour H et al. Sequential biventricular pacing: evaluation of safety and efficacy. Pacing Clin. Electrophysiol. 27, 339–345 (2004).
   PubMed Web of Science ®Google Scholar
• Blanc JJ, Bertault-Valls V, Fatemi M, Gilard M, Pennec PY, Etienne Y. Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation 109, 1741–1744 (2004).
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Butter C et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J. Am. Coll. Cardiol. 42, 2109–2116 (2003).
   PubMed Web of Science ®Google Scholar
• Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104, 557–567 (2001).
   PubMed Web of Science ®Google Scholar
• Mogensen J, Murphy RT, Shaw T et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 44, 2033–2040 (2004).
   PubMed Web of Science ®Google Scholar
• Murphy RT, Mogensen J, Shaw A, Kubo T, Hughes S, McKenna WJ. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 363, 371–372 (2004).
   PubMed Web of Science ®Google Scholar
• Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280, 750–752 (1998).
   PubMed Web of Science ®Google Scholar
• Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of α-tropomyosin are associated with dilated cardiomyopathy. J. Mol. Cell Cardiol. 33, 723–732 (2001).
   PubMed Web of Science ®Google Scholar
• Kamisago M, Sharma SD, DePalma SR et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med. 343, 1688–1696 (2000).
   PubMed Web of Science ®Google Scholar
• Gerull B, Gramlich M, Atherton J et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature Genet. 30, 201–204 (2002).
   PubMed Web of Science ®Google Scholar
• Itoh-Satoh M, Hayashi T, Nishi H et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 291, 385–393 (2002).
   PubMed Web of Science ®Google Scholar
• Daehmlow S, Erdmann J, Knueppel T et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 298, 116–120 (2002).
   PubMed Web of Science ®Google Scholar
• Knoll R, Hoshijima M, Hoffman HM et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111, 943–955 (2002).
   PubMed Web of Science ®Google Scholar
• Fatkin D, MacRae C, Sasaki T et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341, 1715–1724 (1897).
   Google Scholar
• Bione S, Maestrini E, Rivella S et al. Identification of a novel X-linked gene responsible for Emery–Dreifuss muscular dystrophy. Nature Genet. 8, 323–327 (1994).
   PubMed Web of Science ®Google Scholar
• Li D, Tapscoft T, Gonzalez O et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100, 461–464 (1897).
   Google Scholar
• Tsubata S, Bowles KR, Vatta M et al. Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest. 106, 655–662 (2000).
   PubMed Web of Science ®Google Scholar
• Muntoni F, Cau M, Ganau A et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329, 921–925 (1993).
   PubMed Web of Science ®Google Scholar
• Norgett EE, Hatsell SJ, Carvajal-Huerta L et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet. 9, 2761–2766 (2000).
   PubMed Web of Science ®Google Scholar
• Olson TM, Illenberger S, Kishimoto NY, Huttelmaier S, Keating MT, Jockusch BM. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105, 431–437 (2002).
   PubMed Web of Science ®Google Scholar
• Mohapatra B, Jimenez S, Lin JH et al. Mutations in the muscle LIM protein and α-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab. 80, 207–215 (2003).
   PubMed Web of Science ®Google Scholar
• Vatta M, Mohapatra B, Jimenez S et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol. 42, 2014–2027 (2003).
   PubMed Web of Science ®Google Scholar
• Schmitt JP, Kamisago M, Asahi M et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410–1413 (2003).
   PubMed Web of Science ®Google Scholar
• Bienengraeber M, Olson TM, Selivanov VA et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nature Genet. 36, 382–387 (2004).
   PubMed Web of Science ®Google Scholar
• Ichida F, Tsubata S, Bowles KR et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103, 1256–1263 (2001).
   PubMed Web of Science ®Google Scholar
• Chen R, Tsuji T, Ichida F et al. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol. Genet. Metab. 77, 319–325 (2002).
   PubMed Web of Science ®Google Scholar
• Suomalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340, 1319–1320 (1992).
   PubMedGoogle Scholar
• Barrans JD, Allen PD, Stamatiou D, Dzau VJ, Liew CC. Global gene expression profiling of end stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am. J. Pathol. 160, 2035–2043 (2002).
   Google Scholar
• Kaab S, Barth AS, Margerie D et al. Global gene expression in human myocardium–oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J. Mol. Med. 82, 308–316 (2004).
   Google Scholar